Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Schizophrenia

  Free Subscription


Articles published in J Psychiatry Neurosci

Retrieve available abstracts of 22 articles:
HTML format



Single Articles


    July 2025
  1. FABIANO N, Zhou C, Wong S, Correll CU, et al
    Switching to a muscarinic agonist to alleviate antipsychotic-induced metabolic and neuromotor adverse effects in a person living with schizophrenia.
    J Psychiatry Neurosci. 2025;50:E200-E201.
    PubMed    


  2. MASON AJC, Harada-Laszlo M, Wanduragala M, Tang R, et al
    Childhood trauma and hippocampal-dependent memory across the psychosis spectrum: a systematic review and meta-analysis.
    J Psychiatry Neurosci. 2025;50:E277-E298.
    PubMed     Abstract available


    January 2025
  3. DJIMBOUON F, Klar P, Northoff G
    Shorter and inflexible intrinsic neural timescales of the self in schizophrenia.
    J Psychiatry Neurosci. 2025;50:E57-E66.
    PubMed     Abstract available


    November 2024
  4. FAN L, Zhang Z, Ma X, Liang L, et al
    Glutamate levels and symptom burden in high-risk and first-episode schizophrenia: a dual-voxel study of the anterior cingulate cortex.
    J Psychiatry Neurosci. 2024;49:E367-E376.
    PubMed     Abstract available


  5. WANG P, Jiang L, Hu J, Jiang Z, et al
    The amino acid metabolism pathway of peripheral T lymphocytes and ketamine-induced schizophrenia-like phenotype.
    J Psychiatry Neurosci. 2024;49:E413-E426.
    PubMed     Abstract available


    July 2024
  6. ALONSO-SANCHEZ MF, Hinzen W, He R, Gati J, et al
    Perplexity of utterances in untreated first-episode psychosis: an ultra-high field MRI dynamic causal modelling study of the semantic network.
    J Psychiatry Neurosci. 2024;49:E252-E262.
    PubMed     Abstract available


  7. WANG Z, Wu T, Hu H, Alabed AAA, et al
    Plasma exosomes carrying mmu-miR-146a-5p and Notch signalling pathway-mediated synaptic activity in schizophrenia.
    J Psychiatry Neurosci. 2024;49:E265-E281.
    PubMed     Abstract available


    January 2024
  8. SUN Y, Bo Q, Mao Z, Tian Q, et al
    Different levels of prepulse inhibition among patients with first-episode schizophrenia, bipolar disorder and major depressive disorder.
    J Psychiatry Neurosci. 2024;49:E1-E10.
    PubMed     Abstract available


  9. MARTINEZ-PEULA O, Morentin B, Callado LF, Meana JJ, et al
    Permissive epigenetic regulatory mechanisms at the histone level are enhanced in postmortem dorsolateral prefrontal cortex of individuals with schizophrenia.
    J Psychiatry Neurosci. 2024;49:E35-E44.
    PubMed     Abstract available


  10. TANG Y, Tan Y, Palaniyappan L, Yao Y, et al
    Epigenetic profile of the immune system associated with symptom severity and treatment response in schizophrenia.
    J Psychiatry Neurosci. 2024;49:E45-E58.
    PubMed     Abstract available


  11. TUPPURAINEN H, Maatta S, Kononen M, Julkunen P, et al
    Navigated and individual alpha-peak-frequency-guided transcranial magnetic stimulation in male patients with treatment-refractory schizophrenia.
    J Psychiatry Neurosci. 2024;49:E87-E95.
    PubMed     Abstract available


  12. FOREMAN D
    Lessons from studies of medication reduction in psychosis: giving participants accurate information about risk in psychiatric research trials.
    J Psychiatry Neurosci. 2024;49:E81-E86.
    PubMed     Abstract available


  13. PERROTTELLI A, Marzocchi FF, Caporusso E, Giordano GM, et al
    Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models.
    J Psychiatry Neurosci. 2024;49:E109-E125.
    PubMed     Abstract available


  14. MIHALJEVIC M, Nagpal A, Etyemez S, Narita Z, et al
    Neuroimaging alterations and relapse in early-stage psychosis.
    J Psychiatry Neurosci. 2024;49:E135-E142.
    PubMed     Abstract available


  15. DALTON K, Joober R, Karama S, Palaniyappan L, et al
    Making use of N-of-1 trials to treat ADHD in people with psychosis: a hypothetical case.
    J Psychiatry Neurosci. 2024;49:E133-E134.
    PubMed    



  16. Correction to "Improving causality perception judgments in schizophrenia spectrum disorder via transcranial direct current stimulation".
    J Psychiatry Neurosci. 2024;49:E144.
    PubMed    



  17. Correction to "Navigated and individual alpha-peak-frequency-guided transcranial magnetic stimulation in male patients with treatment-refractory schizophrenia".
    J Psychiatry Neurosci. 2024;49:E143.
    PubMed    


    November 2023
  18. CHOE E, Ha M, Choi S, Park S, et al
    Beyond verbal fluency in the verbal fluency task: semantic clustering as a predictor of remission in individuals at clinical high risk for psychosis.
    J Psychiatry Neurosci. 2023;48:E414-E420.
    PubMed     Abstract available


  19. LIU S, Zhong H, Qian Y, Cai H, et al
    Neural mechanism underlying the beneficial effect of Theory of Mind psychotherapy on early-onset schizophrenia: a randomized controlled trial.
    J Psychiatry Neurosci. 2023;48:E421-E430.
    PubMed     Abstract available


  20. HE K, Hua Q, Li Q, Zhang Y, et al
    Abnormal interhemispheric functional cooperation in schizophrenia follows the neurotransmitter profiles.
    J Psychiatry Neurosci. 2023;48:E452-E460.
    PubMed     Abstract available


  21. SUN S, Xiao S, Guo Z, Gong J, et al
    Meta-analysis of cortical thickness reduction in adult schizophrenia.
    J Psychiatry Neurosci. 2023;48:E461-E470.
    PubMed     Abstract available


    September 2023
  22. QUARTO T, Lella A, Di Carlo P, Rampino A, et al
    Heritability of amygdala reactivity to angry faces and its replicable association with the schizophrenia risk locus of miR-137.
    J Psychiatry Neurosci. 2023;48:E357-E366.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.